A211050
DMT-2′O-TBDMS-rA(bz) Phosphoramidite
configured for (ÄKTA® and OligoPilot®)
Manufacturer: Sigma Aldrich
CAS Number: 104992-55-4
Synonym(S): DMT-2’O-TBDMS-rA(bz) Amidite, N-benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-[(1,1-dimethylethyl)dimethylsilyl]-adenosine, 3′-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 2 G | A211050-2-G | In Stock | ₹ 19,701.50 |
| 5 G | A211050-5-G | In Stock | ₹ 48,366.10 |
| 10 G | A211050-10-G | In Stock | ₹ 96,667.25 |
A211050 - 2 G
In Stock
Quantity
1
Base Price: ₹ 19,701.50
GST (18%): ₹ 3,546.27
Total Price: ₹ 23,247.77
biological source
non-animal source (no BSE/TSE risk)
Quality Level
300
product line
Proligo Reagents
Assay
≥99% (31P-NMR)≥99.0% (reversed phase HPLC)
form
powder
technique(s)
oligo synthesis: suitable
impurities
≤0.3% water content (Karl Fischer)≤0.5% P(III) Impurities 100-169ppm (31P-NMR)≤0.5% single Impurity (reversed phase HPLC)≤3% residual Solvent content
color
white to off-white
λ
conforms (UV/VIS Identity)
suitability
conforms to structure for H-NMRconforms to structure for LC-MS
Other Options
Related Products
Description
- General description: RNA phosphoramidites, along with RNA CPG, and analogous to DNA synthesis support the synthesis of sequence-specific RNA oligonucleotides for RNA interference (RNAi) and can be used in target validation and other drug development techniques. Modern phosphoramidite-mediated synthesis has enabled routine high-yielding preparations of RNA oligonucleotides. High-quality RNA phosphoramidites are key to low failure rates, the high biological activity of synthesis products, and cost-effectiveness.Key FeaturesIndustry-standard 2′O-TBDMS protective groupConsistent lot-to-lot purity and performanceCompatible with deprotection methods based on methylamine or AMAStandard RNA phosphoramidites provide excellent coupling results when used with ETT or BTT as an activator; best results are obtained with activator 42Capping with standard acetic anhydride capping reagent rather than with fast Deprotection Cap AManufactured under a certified ISO 9001 quality systemDMT-2′O-TBDMS-rA(bz) Phosphoramidite is configured for ÄKTA and OligoPilot Synthesizers.
- Legal Information: OligoPilot is a registered trademark of Cytiva
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
biological source: non-animal source (no BSE/TSE risk)
Quality Level: 300
product line: Proligo Reagents
Assay: ≥99% (31P-NMR)≥99.0% (reversed phase HPLC)
form: powder
technique(s): oligo synthesis: suitable
impurities: ≤0.3% water content (Karl Fischer)≤0.5% P(III) Impurities 100-169ppm (31P-NMR)≤0.5% single Impurity (reversed phase HPLC)≤3% residual Solvent content
color: white to off-white
λ: conforms (UV/VIS Identity)
suitability: conforms to structure for H-NMRconforms to structure for LC-MS
biological source:
non-animal source (no BSE/TSE risk)
Quality Level:
300
product line:
Proligo Reagents
Assay:
≥99% (31P-NMR)≥99.0% (reversed phase HPLC)
form:
powder
technique(s):
oligo synthesis: suitable
impurities:
≤0.3% water content (Karl Fischer)≤0.5% P(III) Impurities 100-169ppm (31P-NMR)≤0.5% single Impurity (reversed phase HPLC)≤3% residual Solvent content
color:
white to off-white
λ:
conforms (UV/VIS Identity)
suitability:
conforms to structure for H-NMRconforms to structure for LC-MS
biological source: non-animal source (no BSE/TSE risk)
Quality Level: 300
product line: Proligo Reagents
Assay: ≥99% (31P-NMR)≥99.0% (reversed phase HPLC)
form: powder
technique(s): oligo synthesis: suitable
impurities: ≤0.1% single unspecified Impurity (reversed phase HPLC)≤0.3% mA2 (reversed phase HPLC, Hydrolysate)≤0.3% mA3 (reversed phase HPLC, DMT-rA(bz)me)≤0.3 wt. % water content (Karl Fischer)≤0.5% P(III) Impurities 100-169ppm (31P-NMR)≤1.0% mA1 (reversed phase HPLC, DMT-rA(bz)me-DMT)≤3 wt. % residual Solvent content
color: white to off-white
λ: conforms (UV/VIS Identity)
suitability: conforms to structure for H-NMRconforms to structure for LC-MS
biological source:
non-animal source (no BSE/TSE risk)
Quality Level:
300
product line:
Proligo Reagents
Assay:
≥99% (31P-NMR)≥99.0% (reversed phase HPLC)
form:
powder
technique(s):
oligo synthesis: suitable
impurities:
≤0.1% single unspecified Impurity (reversed phase HPLC)≤0.3% mA2 (reversed phase HPLC, Hydrolysate)≤0.3% mA3 (reversed phase HPLC, DMT-rA(bz)me)≤0.3 wt. % water content (Karl Fischer)≤0.5% P(III) Impurities 100-169ppm (31P-NMR)≤1.0% mA1 (reversed phase HPLC, DMT-rA(bz)me-DMT)≤3 wt. % residual Solvent content
color:
white to off-white
λ:
conforms (UV/VIS Identity)
suitability:
conforms to structure for H-NMRconforms to structure for LC-MS
biological source: non-animal source (no BSE/TSE risk)
Quality Level: 300
product line: Proligo Reagents
Assay: ≥99% (31P-NMR)≥99.0% (redox titration)
form: powder
technique(s): __
impurities: ≤0.3% mA2 (reversed phase HPLC, Hydrolysate)≤0.3% mA3 (reversed phase HPLC, DMT-rA(bz)me)≤0.3% water content (Karl Fischer)≤0.5% P(III) Impurities 100-169ppm (31P-NMR)≤0.5% single Impurity (redox titration)≤1.0% mA1 (reversed phase HPLC, DMT-rA(bz)me-DMT)≤3% residual Solvent content
color: white to off-white
λ: __
suitability: conforms to structure for H-NMRconforms to structure for LC-MS
biological source:
non-animal source (no BSE/TSE risk)
Quality Level:
300
product line:
Proligo Reagents
Assay:
≥99% (31P-NMR)≥99.0% (redox titration)
form:
powder
technique(s):
__
impurities:
≤0.3% mA2 (reversed phase HPLC, Hydrolysate)≤0.3% mA3 (reversed phase HPLC, DMT-rA(bz)me)≤0.3% water content (Karl Fischer)≤0.5% P(III) Impurities 100-169ppm (31P-NMR)≤0.5% single Impurity (redox titration)≤1.0% mA1 (reversed phase HPLC, DMT-rA(bz)me-DMT)≤3% residual Solvent content
color:
white to off-white
λ:
__
suitability:
conforms to structure for H-NMRconforms to structure for LC-MS
biological source: non-animal source (no BSE/TSE risk)
Quality Level: 300
product line: Proligo Reagents
Assay: ≥99% (31P-NMR)≥99.0% (reversed phase HPLC)
form: powder
technique(s): oligo synthesis: suitable
impurities: ≤0.1% single unspecified Impurity (reversed phase HPLC)≤0.3% mA2 (reversed phase HPLC, Hydrolysate)≤0.3% mA3 (reversed phase HPLC, DMT-rA(bz)me)≤0.3% water content (Karl Fischer)≤0.5% P(III) Impurities 100-169ppm (31P-NMR)≤1.0% mA1 (reversed phase HPLC, DMT-rA(bz)me-DMT)≤3% residual Solvent content
color: white to off-white
λ: conforms (UV/VIS Identity)
suitability: conforms to structure for H-NMRconforms to structure for LC-MS
biological source:
non-animal source (no BSE/TSE risk)
Quality Level:
300
product line:
Proligo Reagents
Assay:
≥99% (31P-NMR)≥99.0% (reversed phase HPLC)
form:
powder
technique(s):
oligo synthesis: suitable
impurities:
≤0.1% single unspecified Impurity (reversed phase HPLC)≤0.3% mA2 (reversed phase HPLC, Hydrolysate)≤0.3% mA3 (reversed phase HPLC, DMT-rA(bz)me)≤0.3% water content (Karl Fischer)≤0.5% P(III) Impurities 100-169ppm (31P-NMR)≤1.0% mA1 (reversed phase HPLC, DMT-rA(bz)me-DMT)≤3% residual Solvent content
color:
white to off-white
λ:
conforms (UV/VIS Identity)
suitability:
conforms to structure for H-NMRconforms to structure for LC-MS